Wimmer Associates 1, LLC Bristol Myers Squibb CO Transaction History

Wimmer Associates 1, LLC

$190 Million
Q1 2024

A detailed history of Wimmer Associates 1, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 4,180 shares of BMY stock, worth $167,158. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,180

Previous 4,090 2.2%

Holding current value

$167,158

Previous $209,000 8.13%

% of portfolio

0.12%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $4,318 - $4,896	90 Added 2.2%	4,180 $226,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $10,180 - $12,148	-210 Reduced 4.88%	4,090 $209,000
Q1 2023 May 16, 2023	SELL	$65.71 - $74.53 $22,341 - $25,340	-340 Reduced 7.33%	4,300 $298,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $3,631 - $3,999	-50 Reduced 1.07%	4,640 $357,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $15,384 - $18,020	-260 Reduced 5.25%	4,690 $278,000

Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $21,358 - $23,259	-345 Reduced 6.52%	4,950 $331,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $1,483 - $1,668	25 Added 0.47%	5,295 $334,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $1,443 - $1,635	25 Added 0.48%	5,270 $327,000
Q3 2020 Dec 03, 2020	BUY	$57.43 - $63.64 $33,022 - $36,593	575 Added 12.31%	5,245 $316,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $28,780 - $33,647	-525 Reduced 10.11%	4,670 $289,000
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $23,523 - $27,890	-550 Reduced 9.57%	5,195 $263,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $8,924 - $9,868	-200 Reduced 3.36%	5,745 $261,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $14,212 - $16,947	315 Added 5.6%	5,945 $284,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $23,892 - $30,982	-490 Reduced 8.01%	5,630 $293,000
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $8,278 - $9,337	150 Added 2.51%	6,120 $380,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $38,150 - $47,549	-755 Reduced 11.23%	5,970 $330,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $11,684 - $13,451	-195 Reduced 2.82%	6,725 $425,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $8,391 - $9,149	140 Added 2.06%	6,920 $424,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $18,778 - $21,671	340 Added 5.28%	6,780 $432,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,440	6,440 $359,000

Others Institutions Holding BMY

# of Institutions

2,555

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.

Account

Wimmer Associates 1, LLC Bristol Myers Squibb CO Transaction History